BIOMARIN PHARMACEUTICAL INC (BMRN)
US09061G1013 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.846B -0.76% | 2.096B 13.52% | 2.419B 15.42% | 2.876B 18.88% | 3.158B 9.81% | 3.469B 9.85% | 3.65B 5.22% | 3.825B 4.79% | 3.947B 3.19% | 4.114B 4.23% | 4.017B -2.36% | |
| EBITDA YoY % growth | 24.2M 175.00% | 166.6M 588.43% | 262.483M 57.55% | 576.68M 119.70% | 866.47M 50.25% | 1.123B 29.61% | 1.167B 3.92% | 1.33B 13.97% | 1.475B 10.90% | 1.622B 9.97% | 1.698B 4.69% | |
| EBIT YoY % growth | -83.8M 13.07% | 64.6M 177.09% | 158.097M 144.73% | 475.84M 200.98% | 768.83M 61.57% | 1.006B 30.85% | 1.144B 13.72% | 1.289B 12.67% | 1.431B 11.02% | 1.54B 7.62% | 1.481B -3.83% | |
| Operating Margin | -4.54% | 3.08% | 6.54% | 16.55% | 24.35% | 29.00% | 31.34% | 33.70% | 36.26% | 37.43% | 36.87% | |
| EPS YoY % growth | -0.36 -107.91% | 0.29 180.56% | 0.95 227.59% | 2.09 119.97% | 3.04 45.33% | 4.04 32.90% | 5.69 41.08% | 6.59 15.67% | 7.16 8.78% | 7.45 4.01% | 7.12 -4.50% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.55 203.82% | 0.63 37.48% | 0.70 24.85% | 0.75 36.06% | 0.78 42.87% | 0.72 13.31% | 0.74 6.13% | 0.76 2.03% | 0.76 -2.35% |
| Revenue Q2Q % growth | 727.77M 12.62% | 741.51M 14.28% | 770.5M 8.21% | 789.5M 5.87% | 806.25M 10.78% | 848.98M 14.49% | 857.1M 11.24% | 880.86M 11.57% | 863.91M 7.15% |
| EBITDA Q2Q % growth | 181.63M 53.14% | 175.32M 65.69% | 186.58M -12.52% | 216M -6.18% | 267.88M 47.49% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 125.67M 783.82% | 144.31M 83.92% | 165.35M 3.68% | 179.52M 14.04% | 177.58M 41.31% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.55 161.90% | 0.53 | 0.02 | 4.22% |
| Q2 2024 Q2Q % growth | 0.56 93.10% | 0.36 | 0.20 | 57.23% |
| Q1 2024 Q2Q % growth | 0.46 70.37% | 0.35 | 0.11 | 30.72% |
| Q4 2023 Q2Q % growth | 0.18 | 0.24 | -0.06 | -24.46% |
| Q3 2023 Q2Q % growth | 0.21 625.00% | 0.24 | -0.03 | -12.05% |
| Q2 2023 Q2Q % growth | 0.29 93.33% | 0.24 | 0.05 | 22.09% |
| Q1 2023 Q2Q % growth | 0.27 50.00% | 0.18 | 0.09 | 47.54% |
| Q4 2022 Q2Q % growth | 0.00 100.00% | -0.07 | 0.07 | 100.00% |
| Q3 2022 Q2Q % growth | -0.04 80.00% | -0.01 | -0.03 | -361.36% |
| Q2 2022 Q2Q % growth | 0.15 114.29% | 0.12 | 0.03 | 29.99% |
| Q1 2022 Q2Q % growth | 0.18 100.00% | 0.18 | 0.00 | 2.52% |
| Q4 2021 Q2Q % growth | -0.32 -366.67% | -0.33 | 0.01 | 2.37% |
| Q3 2021 Q2Q % growth | -0.20 -104.99% | -0.25 | 0.05 | 20.94% |
| Q2 2021 Q2Q % growth | 0.07 450.00% | -0.12 | 0.19 | 158.23% |
| Q1 2021 Q2Q % growth | 0.09 -79.55% | -0.07 | 0.16 | 231.05% |
| Q4 2020 Q2Q % growth | 0.12 50.00% | -0.19 | 0.31 | 161.70% |
| Q3 2020 Q2Q % growth | 4.01 1,236.67% | 1.26 | 2.75 | 218.06% |
| Q2 2020 Q2Q % growth | -0.02 90.48% | -0.10 | 0.08 | 79.94% |
| Q1 2020 Q2Q % growth | 0.44 237.50% | 0.05 | 0.39 | 723.70% |
| Q4 2019 Q2Q % growth | 0.08 500.00% | -0.06 | 0.14 | 224.77% |
| Q3 2019 Q2Q % growth | 0.30 528.57% | 0.06 | 0.24 | 398.93% |
| Q2 2019 Q2Q % growth | -0.21 | -0.12 | -0.09 | -79.03% |
| Q1 2019 Q2Q % growth | -0.32 -28.00% | -0.19 | -0.13 | -64.25% |
| Q4 2018 Q2Q % growth | -0.02 | -0.25 | 0.23 | 92.02% |
| Q3 2018 Q2Q % growth | -0.07 | -0.22 | 0.15 | 68.21% |
| Q2 2018 Q2Q % growth | -0.21 | -0.18 | -0.03 | -18.07% |
| Q1 2018 Q2Q % growth | -0.25 | -0.20 | -0.05 | -26.34% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 745.74M 28.28% | 714.18M | 31.56M | 4.42% |
| Q2 2024 Q2Q % growth | 712.029M 19.61% | 675.29M | 36.739M | 5.44% |
| Q1 2024 Q2Q % growth | 648.833M 8.79% | 664.82M | -15.987M | -2.40% |
| Q4 2023 Q2Q % growth | 646.207M 20.22% | 649.62M | -3.413M | -0.53% |
| Q3 2023 Q2Q % growth | 581.329M 15.05% | 620.85M | -39.521M | -6.37% |
| Q2 2023 Q2Q % growth | 595.275M 11.52% | 607.14M | -11.865M | -1.95% |
| Q1 2023 Q2Q % growth | 596.415M 14.83% | 582.04M | 14.375M | 2.47% |
| Q4 2022 Q2Q % growth | 537.5M 19.50% | 547.71M | -10.21M | -1.86% |
| Q3 2022 Q2Q % growth | 505.3M 23.64% | 528.78M | -23.48M | -4.44% |
| Q2 2022 Q2Q % growth | 533.8M 6.40% | 531.9M | 1.9M | 0.36% |
| Q1 2022 Q2Q % growth | 519.4M 6.87% | 517.67M | 1.73M | 0.33% |
| Q4 2021 Q2Q % growth | 449.8M -0.51% | 451.23M | -1.43M | -0.32% |
| Q3 2021 Q2Q % growth | 408.7M -14.28% | 444.03M | -35.33M | -7.96% |
| Q2 2021 Q2Q % growth | 501.7M 16.81% | 457.47M | 44.23M | 9.67% |
| Q1 2021 Q2Q % growth | 486M -3.21% | 455.38M | 30.62M | 6.72% |
| Q4 2020 Q2Q % growth | 452.1M -0.51% | 449.03M | 3.07M | 0.68% |
| Q3 2020 Q2Q % growth | 476.8M 3.40% | 463.74M | 13.06M | 2.82% |
| Q2 2020 Q2Q % growth | 429.5M 10.75% | 426.99M | 2.51M | 0.59% |
| Q1 2020 Q2Q % growth | 502.1M 25.31% | 478.15M | 23.95M | 5.01% |
| Q4 2019 Q2Q % growth | 454.4M 28.65% | 468.52M | -14.12M | -3.01% |
| Q3 2019 Q2Q % growth | 461.1M 17.72% | 463.64M | -2.54M | -0.55% |
| Q2 2019 Q2Q % growth | 387.8M 4.02% | 423.34M | -35.54M | -8.40% |
| Q1 2019 Q2Q % growth | 400.7M 7.31% | 397.45M | 3.25M | 0.82% |
| Q4 2018 Q2Q % growth | 353.2M | 384.65M | -31.45M | -8.18% |
| Q3 2018 Q2Q % growth | 391.7M | 374.43M | 17.27M | 4.61% |
| Q2 2018 Q2Q % growth | 372.8M | 368.27M | 4.53M | 1.23% |
| Q1 2018 Q2Q % growth | 373.4M | 355.72M | 17.68M | 4.97% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 8.71% | -0.24% | 0.44% |
| Revenue | 0% | -3.34% | -0.03% | 0.81% |